RHÖN-KLINIKUM AG reports 2025 growth amid profit decline and tech upgrades

RHÖN-KLINIKUM AG has reported its financial and operational results for 2025. The company saw revenue growth but faced a drop in profit due to higher costs and lower interest rates. Despite this, it expanded services and introduced advanced medical technology across its hospitals. The group's consolidated revenue rose by 6.8% in 2025, reaching €1,704.7 million. This increase came alongside a 2.5% rise in patient numbers, with 938,650 people treated during the year. However, profit fell to €36.3 million, affected by higher depreciation, asset impairments, and declining interest rates.

New developments were rolled out at all locations, including major upgrades in diagnostic and treatment equipment. In Gießen, a new laboratory line was installed, while Marburg received advanced cardiac catheter technology and a 3 Tesla MRI machine. Bad Berka gained a modern radiotherapy system for cancer care. The group also became the only hospital operator in Germany to use three next-generation photon counting CT scanners.

Looking ahead, RHÖN-KLINIKUM AG expects revenues of around €1.7 billion for 2026, with a possible variation of 5%. EBITDA is forecasted between €110 million and €125 million. The company's leadership has proposed a dividend of €0.20 per share for shareholders. The 2025 results show both growth in patient care and revenue, alongside financial pressures from asset costs. With new technology and expanded services, the group aims to maintain its position in the healthcare sector. Shareholders will vote on the proposed dividend in the coming months.